Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 46Lymphoma, Non-Hodgkin 33Lymphoma, Large B-Cell, Diffuse 32Lymphoma, Mantle-Cell 25Lymphoma, Follicular 21Hodgkin Disease 21Lymphoma, Large-Cell, Immunoblastic 16Glioblastoma 16Leukemia, Lymphocytic, Chronic, B-Cell 15Burkitt Lymphoma 15Brain Neoplasms 14Multiple Myeloma 13Gliosarcoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Central Nervous System Neoplasms 12Leukemia 10Neoplasms, Plasma Cell 9Lymphoma, B-Cell, Marginal Zone 9Glioma 9Astrocytoma 9Oligodendroglioma 5Waldenstrom Macroglobulinemia 4Recurrence 4Lymphoma, T-Cell 4Lymphoma, B-Cell 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 3Lymphoma, T-Cell, Peripheral 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3

Interventions

thymoglobulin 1prednylidene 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Sugars 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Antilymphocyte Serum 14-Aminopyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neuromyelitis Optica × Carmustine × Clear all
NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
53 enrolled
CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡